Profitelligence Profitelligence · Filing Ledger Open CRL research →

Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-08-25

Foster James C Files Charles River Laboratories International (CRL) Form 4 - August 25, 2026

Foster James C traded 67.1K CRL shares worth $16.8M in this Form 4 filing, reported to the SEC on 2026-08-25.

Insider
Foster James C
Issuer
Charles River Laboratories International, Inc. CRL · NYSE
Filed
Period
2026-08-25
Accession
0001100682-26-000140

Transactions (5)

Insider Date Type Shares Price Value Own
Foster James C 2026-08-25 Buy 21.1K $194.12 $4.1M Direct
Foster James C 2026-08-25 Buy 12.4K $208.44 $2.6M Direct
Foster James C 2026-08-25 Sell 33.6K $300.00 $10.1M Direct
Net change0−$3.4M

About Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc. provides essential services to the pharmaceutical, biotechnology, and life sciences industries. The company specializes in preclinical and clinical lab services, offering clients a comprehensive suite of drug discovery and development services that expedite the process of getting new drugs and therapies to the market. Notably, Charles River's facilities offer expertise in the fields of oncology, immunology, and neuroscience, making it a critical partner for companies working in these therapeutic areas. The firm operates globally, enhancing its customers' ability to operate internationally through its wide network of laboratories and testing facilities. By enabling more efficient drug development cycles and reducing the time to market for new therapies, Charles River Laboratories plays a crucial role in the advancement of medical science and patient care worldwide. The company's commitment to high standards of animal welfare and ethical practices further underscores its reputation as a leader in quality and reliability within the research community.

Exchange NYSE Industry Diagnostics & Research Company website ↗

Track CRL insider activity

Get alerted when Charles River Laboratories International, Inc. executives buy or sell their shares.

Set up free alerts